Brian David Archbold - 15 Jun 2026 Form 4 Insider Report for MESA LABORATORIES INC /CO/ (MLAB)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
16 Jun 2026, 14:44:42 UTC
Prior SEC filing
25 Jun 2025
Next SEC filing
17 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
John Sakys under Power of Attorney by Brian Archbold

Key filing fact

Brian David Archbold filed Form 4 for MESA LABORATORIES INC /CO/ (MLAB) on 16 Jun 2026.

Key facts

  • This page summarizes Brian David Archbold's Form 4 filing for MESA LABORATORIES INC /CO/ (MLAB).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 16 Jun 2026, 14:44.

Change

  • Previous filing in this sequence was filed on 25 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001776947 Primary reporting owner

Archbold Brian David

Relationship
SVP Operations
Address
12100 W. 6TH AVENUE, LAKEWOOD
Signature
John Sakys under Power of Attorney by Brian Archbold
Signature date
16 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MLAB transaction

Common Stock

Options Exercise

Transaction value
Shares
+2,454
Change %
+102%
Price
$104.08*
Shares after
4,861
Date
15 Jun 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MLAB transaction Derivative

Non Qualified Stock Options

Expiration of short derivative position

Transaction value
Shares
-1,780
Change %
-13%
Price
$0.000000*
Shares after
11,852
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,780
Exercise price
$226.72
Footnotes
F1
MLAB transaction Derivative

Restricted Stock Units - 9

Options Exercise

Transaction value
Shares
-2,454
Change %
-33%
Price
$0.000000*
Shares after
4,892
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,454
Exercise price
Footnotes
F2, F3, F4
MLAB transaction Derivative

Restricted Stock Units - 10

Award

Transaction value
Shares
+4,328
Change %
Price
$0.000000*
Shares after
4,328
Date
15 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,328
Exercise price
Footnotes
F2, F4, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

NSOs that vested 1/3 on each anniversary date of the June 15, 2020 grant date

Footnote F2

Each RSU represents a contingent right to receive one share of the Issuer's common stock

Footnote F3

RSUs that vest 1/3 on June 15, 2026 and each of the next two anniversary dates

Footnote F4

Not Applicable

Footnote F5

RSUs that vest 34% on June 15, 2027, 33% on June 8, 2028 and 33% on June 8 2029

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .